These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 7529841)
1. [A phase III trial of subcutaneous administration of rhG-CSF in aplastic anemia]. Yoshida Y; Okuma M; Suzuki T; Takahashi T; Nakagawa M; Kashima K; Abe T; Sonoda Y; Fujii H; Haruyama H Rinsho Ketsueki; 1994 Nov; 35(11):1282-8. PubMed ID: 7529841 [TBL] [Abstract][Full Text] [Related]
2. [A phase III trial of subcutaneous administration of rhG-CSF in the myelodysplastic syndromes]. Yoshida Y; Okuma M; Suzuki T; Takahashi T; Nakagawa M; Kashima K; Abe T; Sonoda Y; Fujii H; Haruyama H Rinsho Ketsueki; 1994 Nov; 35(11):1289-96. PubMed ID: 7529842 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of aplastic anemia with KRN8601 (rhG-CSF)]. Kojima S; Matsuyama T; Miyazaki T; Sakurada K; Shike S; Okino E; Akabane T; Nakahata T; Okuni M; Mugishima H Rinsho Ketsueki; 1990 Jul; 31(7):929-36. PubMed ID: 1699006 [TBL] [Abstract][Full Text] [Related]
4. [Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia]. Asano S; Hirashima K; Yoshida Y; Takaku F; Miyazaki T; Omine M; Furusawa S; Abe T; Mori M; Arimori S Rinsho Ketsueki; 1990 Sep; 31(9):1456-62. PubMed ID: 1701008 [TBL] [Abstract][Full Text] [Related]
5. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor). Sonoda Y; Ohno Y; Fujii H; Takahashi T; Nakayama S; Haruyama H; Nasu K; Shimazaki C; Hara H; Kanamaru A Stem Cells; 1993 Nov; 11(6):543-54. PubMed ID: 7509223 [TBL] [Abstract][Full Text] [Related]
7. [Clinical study of rhG-CSF (KRN8601) in patients with myelodysplastic syndrome]. Toyama K; Ohyashiki J; Takaku F; Kobayashi Y; Miyazono K; Miura Y; Sakamoto S; Mizoguchi H; Hoshino S; Urabe A Rinsho Ketsueki; 1990 Jul; 31(7):937-45. PubMed ID: 1699007 [TBL] [Abstract][Full Text] [Related]
8. [Interleukin-3 therapy in patients with aplastic anemia refractory to prior therapies]. Miyairi Y; Murai K; Utsugisawa T; Narigasawa Y; Ito S; Shimosegawa K; Sugawara T; Numaoka H; Ono Y; Ito T; Ishida Y; Kuriya S Rinsho Ketsueki; 1996 Jan; 37(1):22-8. PubMed ID: 8683863 [TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of effects of KRN8601 (rhG-CSF) on neutropenia]. Nakahata T; Akabane T; Miura A; Tada K; Uzuka Y; Hayashi T; Shibata A; Shiko S; Okuni M; Urabe A Rinsho Ketsueki; 1992 Feb; 33(2):123-32. PubMed ID: 1378911 [TBL] [Abstract][Full Text] [Related]
10. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia. Bessho M; Jinnai I; Hirashima K; Saito M; Murohashi I; Ino H; Tsuji M; Fukuda M; Maruyama M; Kusumoto S Stem Cells; 1994 Nov; 12(6):604-15. PubMed ID: 7533579 [TBL] [Abstract][Full Text] [Related]
11. [The effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on childhood neutropenias]. Ueda K; Hanawa Y; Takaku F; Asano S; Tsukimoto I; Tsuchida M; Sato T; Ohira M; Hoshi Y; Nishihira K Rinsho Ketsueki; 1991 Mar; 32(3):212-20. PubMed ID: 1710294 [TBL] [Abstract][Full Text] [Related]
12. [G-CSF (Neupogen Roche) in the treatment of patients with chronic aplastic anemia with severe neutropenia]. Novotný J; Zvarová M; Prazáková L; Jandlová M; Konvicková L Vnitr Lek; 1995 Oct; 41(10):692-5. PubMed ID: 8578701 [TBL] [Abstract][Full Text] [Related]
13. [Streptomycin-induced severe aplastic anemia successfully treated with high-dose methylprednisolone pulse therapy and rhG-CSF]. Umeno Y; Miyamoto Y; Ohta Y Rinsho Ketsueki; 1993 Nov; 34(11):1491-3. PubMed ID: 7504752 [TBL] [Abstract][Full Text] [Related]
14. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)]. Kitamura K; Asano S; Mizoguchi H; Takaku F Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327 [TBL] [Abstract][Full Text] [Related]
15. [Aplastic anemia successfully treated with erythropoietin and rhG-CSF]. Higashino K; Kito K; Hodohara K; Fujiyama Y; Banba T; Hosoda S Rinsho Ketsueki; 1992 Sep; 33(9):1237-41. PubMed ID: 1279235 [TBL] [Abstract][Full Text] [Related]
16. [Effect of subcutaneous administration of interleukin-1 beta on blood platelet count and serum GM-CSF in patients with myelodysplastic syndrome and aplastic anemia]. Furuya H; Ishibashi R; Wakayama T; Ohguni S; Notsu K; Takagi C; Kato Y Rinsho Ketsueki; 1992 Sep; 33(9):1172-7. PubMed ID: 1433938 [TBL] [Abstract][Full Text] [Related]
17. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study. Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A; Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466 [TBL] [Abstract][Full Text] [Related]
18. [Two patients with aplastic anemia successfully treated with G-CSF and erythropoietin]. Hanamura A; Ichikawa A; Utsumi M; Hotta T Rinsho Ketsueki; 1995 Dec; 36(12):1347-52. PubMed ID: 8587170 [TBL] [Abstract][Full Text] [Related]
19. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group. Remacha AF; Arrizabalaga B; Villegas A; Manteiga R; Calvo T; Julià A; Fernández Fuertes I; González FA; Font L; Juncà J; del Arco A; Malcorra JJ; Equiza EP; de Mendiguren BP; Romero M Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205 [TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human granulocyte-colony stimulation factor (rhG-CSF) on immune system in pediatric patients with aplastic anemia. Hibi S; Yoshihara T; Nakajima F; Misu H; Mabuchi O; Imashuku S Pediatr Hematol Oncol; 1994; 11(3):319-23. PubMed ID: 7520260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]